AU Patent

AU2157400A — Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications

Assigned to GD Searle LLC · Expires 2000-07-31 · 26y expired

What this patent protects

Patent listed against Farxiga.

Drugs covered by this patent

Patent Metadata

Patent number
AU2157400A
Jurisdiction
AU
Classification
—
Expires
2000-07-31
Drug substance claim
No
Drug product claim
No
Assignee
GD Searle LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.